| scholarly article | Q13442814 |
| P50 | author | Sujan Shresta | Q28743766 |
| Daniil M Prigozhin | Q52803114 | ||
| Eva Harris | Q5415063 | ||
| P2093 | author name string | Heidi M Snider | |
| P Robert Beatty | |||
| Kristin L Sharar | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| P304 | page(s) | 3946-3954 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice | |
| P478 | volume | 175 |
| Q35235639 | A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection |
| Q37596554 | A mouse model for studying dengue virus pathogenesis and immune response |
| Q33769393 | A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus |
| Q34980624 | A partial form of recessive STAT1 deficiency in humans |
| Q36594860 | A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes |
| Q35572384 | Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice |
| Q34113793 | Activation of the innate immune response against DENV in normal non-transformed human fibroblasts |
| Q38647063 | Animal models for dengue vaccine development and testing. |
| Q40045064 | Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection. |
| Q34018897 | Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in αßγ interferon receptor-deficient mice. |
| Q36951557 | Both NK cell-intrinsic and -extrinsic STAT1 signaling are required for NK cell response against vaccinia virus. |
| Q27480369 | Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage |
| Q37192419 | CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis |
| Q24315236 | CLEC5A is critical for dengue-virus-induced lethal disease |
| Q39128976 | Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses |
| Q27488987 | Cardif-Mediated Signaling Controls the Initial Innate Response to Dengue Virus In Vivo |
| Q92988061 | Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches |
| Q36276591 | Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production |
| Q36887749 | Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication |
| Q39399554 | Current prospects of type II interferon γ signaling and autoimmunity |
| Q35739855 | Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability |
| Q21142740 | Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice |
| Q28278881 | Dengue virus life cycle: viral and host factors modulating infectivity |
| Q36859054 | Development of a transmission model for dengue virus |
| Q35576590 | Differences in type I interferon signaling antagonism by dengue viruses in human and non-human primate cell lines |
| Q41944558 | Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs |
| Q64065850 | Differential Regulation of Type I and Type III Interferon Signaling |
| Q34259867 | Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells |
| Q49569235 | Evaluation of interferon-stimulated genes in peripheral blood granulocytes as sensitive responders to bovine early conceptus signals |
| Q36373118 | Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever |
| Q35599416 | Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection |
| Q41989639 | Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts |
| Q54231570 | Gemcitabine and Nucleos(t)ide Synthesis Inhibitors Are Broad-Spectrum Antiviral Drugs that Activate Innate Immunity. |
| Q59353530 | Host genetic control of mosquito-borne Flavivirus infections |
| Q37793734 | How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections |
| Q38614465 | How flaviviruses activate and suppress the interferon response |
| Q27305770 | IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner |
| Q34046037 | Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections |
| Q47551925 | Immune Response to Dengue and Zika |
| Q36832077 | Immune regulation and evasion of Mammalian host cell immunity during viral infection |
| Q26825342 | Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes |
| Q36733061 | Interferon gamma induces protective non-canonical signaling pathways in primary neurons |
| Q34027764 | Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways |
| Q36604755 | Interferons and viruses: signaling for supremacy. |
| Q34671059 | Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes |
| Q49980492 | Joint ancestry and association test indicate two distinct pathogenic pathways involved in classical dengue fever and dengue shock syndrome |
| Q36086689 | Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. |
| Q40106501 | Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection |
| Q37945197 | Monkeypox virus infections in small animal models for evaluation of anti-poxvirus agents |
| Q35846922 | Mouse STAT2 restricts early dengue virus replication |
| Q27477548 | Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability |
| Q35785067 | Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses |
| Q38211850 | NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells |
| Q24644381 | NS5 of dengue virus mediates STAT2 binding and degradation |
| Q40097417 | Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons |
| Q37145314 | Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling |
| Q39063455 | Pathology caused by persistent murine norovirus infection |
| Q27477646 | Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis |
| Q45868197 | Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity |
| Q38185399 | STAT2 and IRF9: Beyond ISGF3. |
| Q27312177 | STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor |
| Q45017668 | Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. |
| Q26252507 | Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection |
| Q35837150 | Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection |
| Q27485295 | TRAIL Is a Novel Antiviral Protein against Dengue Virus |
| Q37579607 | The differential interferon responses of two strains of Stat1-deficient mice do not alter susceptibility to HSV-1 and VSV in vivo |
| Q34416579 | The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults |
| Q38220346 | The role of cell proteins in dengue virus infection |
| Q37227364 | The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus |
| Q40039016 | Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection |
| Q27480996 | Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 |
| Q33744074 | Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines |
| Q48221758 | Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9. |
| Q99633937 | Type II interferon signaling in the brain during a viral infection with age-dependent pathogenesis |
Search more.